SUSPENDED

Virtual Reality in Reducing Pain and Anxiety in Cancer Participants Undergoing Painful Procedures

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This trial studies how well virtual reality (VR) works in reducing pain and anxiety in cancer participants undergoing bone marrow biopsy or lumbar puncture. Virtual reality may impact pain and anxiety during and after the procedure.

Official Title

Effects of Virtual Reality on Pain and Anxiety in Cancer Patients Undergoing Painful Procedures

Quick Facts

Study Start:2022-03-01

Study Completion:2027-03-01

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:SUSPENDED

Study ID

NCT03568292

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 70 Years

Sexes Eligible for Study:ALL

Accepts Healthy Volunteers:No

Standard Ages:ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Patient has been diagnosed with any cancer * Patient is currently hospitalized and receiving treatment for a primary or secondary cancer at University of Southern California (USC) Norris Comprehensive Cancer Center and Hospital * Patient is undergoing a bone marrow biopsy or lumbar puncture	* Inability to sign informed assent and/or consent * Patient with an underlying diagnosis of epilepsy, dementia, Parkinson?s disease, primary central nervous system malignancy, brain metastasis, underlying inflammatory or infectious central nervous system disorder, inner ear infection, history of vertigo, baseline visual or hearing impairment, macular degeneration, untreated glaucoma, implantable medical devices or any medical condition that investigator deems contraindicated * Patient with an underlying chronic pain disorder, anxiety disorder, depressive disorder, or other psychiatric illness unspecified * Patient with active Clostridium difficile infection * Patient on any acute (within last \< 24 hour \[hr\]) or chronic pain medication (opioid, nonsteroidal anti-inflammatory drug \[NSAID\], steroid) * Patient on chronic steroids \> 10 mg prednisone equivalent daily or other immunosuppressant \> 1 week * Patient who is post bone marrow transplant * Patient with a body mass index (BMI) \> 35

Inclusion Criteria

Exclusion Criteria

* Patient has been diagnosed with any cancer
* Patient is currently hospitalized and receiving treatment for a primary or secondary cancer at University of Southern California (USC) Norris Comprehensive Cancer Center and Hospital
* Patient is undergoing a bone marrow biopsy or lumbar puncture

* Inability to sign informed assent and/or consent
* Patient with an underlying diagnosis of epilepsy, dementia, Parkinson?s disease, primary central nervous system malignancy, brain metastasis, underlying inflammatory or infectious central nervous system disorder, inner ear infection, history of vertigo, baseline visual or hearing impairment, macular degeneration, untreated glaucoma, implantable medical devices or any medical condition that investigator deems contraindicated
* Patient with an underlying chronic pain disorder, anxiety disorder, depressive disorder, or other psychiatric illness unspecified
* Patient with active Clostridium difficile infection
* Patient on any acute (within last \< 24 hour \[hr\]) or chronic pain medication (opioid, nonsteroidal anti-inflammatory drug \[NSAID\], steroid)
* Patient on chronic steroids \> 10 mg prednisone equivalent daily or other immunosuppressant \> 1 week
* Patient who is post bone marrow transplant
* Patient with a body mass index (BMI) \> 35

Contacts and Locations

Principal Investigator

Jacek Pinski, MD

PRINCIPAL_INVESTIGATOR

University of Southern California

Study Locations (Sites)

USC / Norris Comprehensive Cancer Center

Los Angeles, California, 90033

United States

Collaborators and Investigators

Sponsor: University of Southern California

Jacek Pinski, MD, PRINCIPAL_INVESTIGATOR, University of Southern California

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-03-01

Study Completion Date2027-03-01

Study Record Updates

Study Start Date2022-03-01

Study Completion Date2027-03-01

Terms related to this study

Additional Relevant MeSH Terms

Malignant Neoplasm